Biopharma Pipeline

To help our patients, GBS Global Biopharma is creating a pipeline for the development of novel medicines based on our own patent-pending formulations of chemicals extracted from the Cannabis plant.

 

GBS Global Biopharma has now filed eight patent applications and licensed three approved patents.